Anatomic Pathology Market To Reach $58.42 Billion By 2030

Anatomic Pathology Market Growth & Trends 

The global anatomic pathology market size is expected to reach USD 58.42 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to grow at a CAGR of 8.7% from 2023 to 2030. The advent of technology in the instruments and the protocols used during the anatomic pathological procedures is anticipated to increase the adoption rate of advanced anatomic pathological instruments.

Market players are collaborating for the refurbishment of pathology products by the incorporation of innovative disease diagnostic models. In April 2021, Leica Biosystems collaborated with Paige, an AI-based diagnostics company, for expanded access to computational pathology products for translational and clinical research. Under this partnership, Paige’s AI-enabled research software and Leica Biosystems’ digital pathology platform were combined. This, in turn, accelerates investments in the up-gradation of pathological equipment.

Pathology-training programs offered to pathologist trainees by public and private entities drive the market. For instance, the Accreditation Council for Graduate Medical Education accredited residency programs for anatomic pathology provide education and training to individuals via numerous teaching conferences.

The drug discovery and development application segment are expected to witness the fastest growth over the forecast period due to the shifting paradigm from conventional medicine to personalized medicine. This is primarily due to the growing reliance on discoveries of putative biomarkers for the development of personalized therapies. Ongoing pathology training programs to ensure that the pathology residents are aware of the developments taking place in the field of personalized medicine have also accelerated the market growth.

North America held the largest revenue share in 2020 owing to a large number of funding programs by public agencies and the presence of key players. Asia Pacific is expected to witness the fastest growth due to the presence of multiple associations that are engaged in conducting pathology training programs.

Key players are undertaking various strategic initiatives such as mergers & acquisitions and new product development to maintain their market presence. For instance, in May 2021, CellCarta acquired Reveal Biosciences, an AI-based pathology firm. This acquisition is aimed at expanding CellCarta’s offerings in AI-enabled multi-omic data analysis services and applications.

 Request a free sample copy or view report summary: Anatomic Pathology Market Report

Anatomic Pathology Market Report Highlights

• By product and services, the consumables segment accounted for the largest share in 2022. High availability, low cost, and a frequent purchase rate of consumables contributed to the segment growth

• The instruments product and services segment is expected to witness the fastest growth over the forecast period. Technological advancements in instruments to minimize the risk of errors through the integration of novel design are expected to drive the segment

• The disease diagnosis application segment dominated the market in 2022 owing to the increasing role of anatomic pathological tools in identifying any anomalies that help diagnose a condition. The use of biomarkers for tracking and identifying infections and diseases during diagnostic processes is expected to boost the growth of the segment

• In terms of end use, the hospitals segment captured the largest share in 2022 due to an increase in the hospitalization rate that stimulates the adoption of pathological workflows for disease monitoring and diagnosis

• The diagnostic laboratories end-use segment growth is facilitated by the use of state-of-the-art laboratory equipment and instrumentation, multiple electronic interfaces, and information systems

Anatomic Pathology Market Segmentation

Grand View Research has segmented the global anatomic pathology market on the basis of product and services, application, end-use, and region:

Anatomic Pathology Product & Services Outlook (Revenue in USD Million, 2018 - 2030)

• Instruments

  • Microtomes & Cryostat

  • Tissue Processors

  • Automatic Stainers

  • Whole Slide Imaging (WSI) Scanners

  • Other Products

• Consumables

  • Reagents & Antibodies

  • Probes & Kits

  • Others

• Services

Anatomic Pathology Application Outlook (Revenue in USD Million, 2018 - 2030)

• Disease Diagnosis

• Drug Discovery and Development

• Others

Anatomic Pathology End-use Outlook (Revenue in USD Million, 2018 - 2030)

• Hospitals

• Research Laboratories

• Diagnostic Laboratories

• Others

Anatomic Pathology Regional Outlook (Revenue in USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List Of Key Players in the Anatomic Pathology Market

• Danaher

• PHC Holdings Corporation

• Quest Diagnostics Incorporated

• Laboratory Corporation of America Holdings

• F. Hoffmann-La Roche AG

• Agilent Technologies, Inc.

• Cardinal Health

• Sakura Finetek USA, Inc.

• NeoGenomics Laboratories, Inc.

• BioGenex

• Bio SB